Powered by

Gilead's Kite Pharma unit nabs Marincola to head up its cell therapy research

Jan 19, 2021 - FierceBiotech
Board and Executive Moves

AbbVie and National Institutes of Health veteran Francesco Marincola, M.D., will become Gilead's new head of cell therapy research out of its Kite unit.

AbbVie and National Institutes of Health (NIH) veteran Francesco Marincola, M.D., will become Gilead's new head of cell therapy research out of its Kite unit.

He replaces Peter Emtage, Ph.D., who quit the company a few months back for a foray into venture capital work at Versant.

Marincola's official role as senior vice pres...